SUBCLINICAL HYPOTHYROIDISM IN WOMEN IN THE ANDIJAN REGION

Authors

  • D. Abdurazzakova Andijan State Medical Institute Department of Hospital Therapy and Endocrinology
  • R Kamoldinov Andijan State Medical Institute Department of Hospital Therapy and Endocrinology
  • M. Nishanova Andijan State Medical Institute Department of Hospital Therapy and Endocrinology
  • R. Umurzakova Andijan State Medical Institute Department of Hospital Therapy and Endocrinology

Keywords:

free tyroxin, prevalence, subclinical hypothyroidism, thyroid hormone, thyroid hormones.

Abstract

The reduction of thyroid hormones in organs and tissues leads to the development of hypothyroidism. Uzbekistan belongs to a region with an iodine deficiency. Measures are being taken to prevent iodine deficiency disorders. Work has been done to assess the occurrence of subclinical hypothyroidism (SU) in women living in the Shahrhigan district ( village Sohiobod) of the Andijan region.
Among women aged between 18 and 65, the SG rate was 12 per cent, with a higher rate than among women aged over 40 than among those aged under 30. In the group of women with TTT >2.5mME/L, anti-TTPA was found to be higher than standard values in 32% of women, while in the group of women with TTG >4.05mME/L with TTG concentrations >26%. Excess body weight was found in 47% (30.8%) and obesity was found in 16% (10.2%) women surveyed.

References

Gasparjan Je. G., Ostashko G. A., Gasparjan A. A., Dymnova S. E. Osobennosti lechenija gipotireoza u lic pozhilogo vozrasta//Lechashhij vrach.- 2012.- №11.S.25-29.

Demidova T.Ju., Galieva O.R. K voprosu lechenija subklinicheskogo gipotireoza u bol'nyh ozhireniem//Klinicheskaja i jeksperimental'naja tireoidologija.- 2008.- T.4,№1.- S.48-52.

Ismailov S.I, Rashitov M.M. Progress v oblasti profilaktiki jododeficitnyh zabolevanij v Respublike Uzbekistan (1998-2016)/ Klinicheskaja i jeksperimental'naja tireoidologija – 2016.№ 3, Tom 12

Ismailov S.I, Rashitov M.M. Rezul'taty jepidemiologicheskih issledovanij rasprostranennosti jododeficitnyh zabolevanij v Respublike Uzbekistan./ Mezhdunarodnyj jendokrinologicheskij zhurnal.- 2017. № 3, Tom 13

Baloch Z., Carayon P., Conte-Devolx B. et al., Guidelines Committee, National Academy of Clinical Biochemistry. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease//Thyroid. - 2003. – Vol.13. – P.3-126.

Brabant G., Peck-Peccoz P., Jarsab B., Laurberg P., Wiersinga W. Is there a need to redefine the upper normal limit of TSH?//Eur J Endocrinol.- 2006.- Vol.154.- R.633–637.

Canaris G., Manowitz N., Mayor G., Ridgway E. The Colorado thyroid disease prevalence study//Arch Intern Med. – 2000.- Vol.160.- P.526-534.

Cooper D. Subclinical hypothyroidism//N Engl J Med. – 2001.- Vol.345(4).- P.260-265.

Fatourechi V., Klee G., Grebe S. et al. Effects of reducing the upper limit of normal TSH values//JAMA. – 2003. - Vol.290. – P. 3195-3196.

Hollowell J., Staehling N., Flanders W. et al. Serum TSH, T4 and thyroid antibodies in the United States population (1988–1994): National Health and Nutrition Examination Survey (NHANES III)//J. Clin. Endocrinol. Metab. - 2002. – Vol. 87. –P.489-499.

Mahato R., Nepal A., Gelal B., Poudel B., Yadav B., Lamsal M. Spectrum of thyroid dysfunction in patients visiting Kantipur Hospital, Kathmandu, Nepal//Mymensingh Med J. – 2013.- Vol.22(1).- P.164-169.

Nakajima Y., Yamada M. Subclinical thyroid disease//Nihon Rinsho. – 2012.- Vol.70(11).- P.1865-1871.

Surks M., Ortiz E., Daniels G., Sawin C., Col N., Cobin R. et al. Subclinical thyroid disease: scientihc review and guidelines for diagnosis and management//JAMA.- 2004.- Vol.291.- P.228-238.

Surks M., Hollowell J. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism//J Clin Endocrinol Metab. – 2007.- Vol.92(12).- P.4575-4582.

Unnikrishnan A., Kalra S., Sahay R., Bantwal G., John M., Tewari N. Prevalence of hypothyroidism in adults: An epidemiological study in eight cities of India//Indian J Endocrinol Metab. – 2013.- Vol.17(4).- P.647-652.

Vanderpump M., Tunbridge W. Epidemiology and prevention of clinical and subclinical hypothyroidism//Thyroid. - 2002.- Vol.12. -P.839–847.

Wartofsky L., Dickey R. Controversy in clinical endocrinology: the evidence for a narrower thyrotropin reference range is compelling//J Clin Endocrinol Metab.- 2005.- Vol.90.- R.5483–5488.

Yadav R., Magar N., Poudel B., Yadav N., Yadav B. A prevalence of thyroid disorder in Western part of Nepal//J Trace Elem Med Biol. – 2013.- Vol.27(2).- P.122-125.

Published

2021-12-30

Issue

Section

Статьи